Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non‐squamous non‐small cell lung cancer

BACKGROUND: Chemoradiotherapy is the standard treatment for locally advanced non‐small cell lung cancer (NSCLC); however, it is disputed whether this treatment is suitable for patients aged ≥75. This study was conducted to determine the maximum tolerated dose (MTD) of pemetrexed for use in concurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Takemoto, Shinnosuke, Nakamura, Yoichi, Fukuda, Minoru, Senju, Hiroaki, Gyotoku, Hiroshi, Taniguchi, Hirokazu, Shimada, Midori, Ikeda, Takaya, Yamaguchi, Hiroyuki, Nakatomi, Katsumi, Hayashi, Nobuyuki, Soda, Hiroshi, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668476/
https://www.ncbi.nlm.nih.gov/pubmed/28771961
http://dx.doi.org/10.1111/1759-7714.12483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668476/
https://www.ncbi.nlm.nih.gov/pubmed/28771961
http://dx.doi.org/10.1111/1759-7714.12483

Ejemplares similares